Immuneering CorporationIMRXNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
0.00%
↑ 100% vs avg
Percentile
P67
Within normal range
Average
-2711.13%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.00% | - |
| 2024 | 0.00% | - |
| 2023 | 0.00% | +100.0% |
| 2022 | -16238.45% | -901.4% |
| 2021 | -1621.52% | -120.4% |
| 2020 | -735.58% | -92.4% |
| 2019 | -382.35% | - |